Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-27

Clinical Trial Update: The ROAMM-EHR Study [NA]

View source ↗

Summary

The ROAMM-EHR study, sponsored by the University of Florida, is currently recruiting. It evaluates treatment options for Peripheral Arterial Disease and Chronic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Florida | Conditions: Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia | NA | Status: RECRUITING